Moc-L-Tert-Leucine CAS 162537-11-3 Mama ≥99.0% (HPLC) Atazanavir Intermediate Factory
Tuuina atu a le Faumea ma le Mamalu Maualuga ma le Tulaga Lelei
Igoa vaila'au: Moc-L-Tert-Leucine
CAS: 162537-11-3
Vaitaimi ole Atazanavir HIV-1 Protease Inhibitor
Tulaga Maualuga, Gaosiga Fa'apisinisi
Igoa Vailaau | Moc-L-Tert-Leucine |
Synonyms | Methoxycarbonyl-L-tert-Leucine;N-(Methoxycarbonyl)-tert-Leucine;Atazanavir Related Compound A |
Numera CAS | 162537-11-3 |
CAT Numera | RF-PI289 |
Tulaga Fa'asoa | I Fa'atauga, Oloa Fua e O'o i Tone |
Fuafua mole | C8H15NO4 |
Molecular Weight | 189.21 |
Lisi Lisi | 109℃ |
Malosi | 1.126 g/cm3 |
Fa'apuna | 320.9 ℃ ile 760 mmHg |
Solubility | Solu i le Ethyl Acetate ma Methanol |
Tulaga Va'a | La'uina i lalo ole vevela ole ambient |
Fa'ailoga | Ruifu Chemical |
Aitema | Fa'amatalaga |
Fa'aaliga | Pa'epa'e e o'o i ma'a-Pa'epa'e |
Faiga Fa'ailoa | HPLC |
Fa'amama/su'esu'ega Metotia | ≥99.0% (HPLC) |
Moc-L-Tle-Tle-OH | ≤0.30% |
L-Moc-Dimer | ≤0.30% |
L-Tle-OH | ≤0.10% |
Methoxycarbonyl-L-Valine | ≤0.10% |
N-Acetyl-L-tert-Leucine | ≤0.05% |
Le Fa'aleaga Tagata Ta'ito'atasi | ≤0.30% |
Aofa'i Fa'aleaga | ≤1.0% |
Enantiomer Content | ≤0.10% (Saunia e Chiral HPLC) |
Suavai Suavai | ≤0.50% (Saunia e KF) |
Ma'imau ile Fa'amago | ≤0.50% |
Toega i luga o le mumu | ≤0.20% |
Metala mamafa | ≤10ppm |
Fa'aoga | Amino acid;Intermediate of Atazanavir (CAS 198904-31-3) |
afifi: Fagu, ato pepa alumini, 25kg/Drum, po'o le tusa ai ma manaoga o tagata faatau.
Tulaga teuina:Teu i totonu o pusa faʻamaufaʻailoga i se nofoaga malulu ma mago;Puipui mai le malamalama, susu.
Shanghai Ruifu Chemical Co., Ltd. o le taʻutaʻua taʻutaʻua ma le tuʻuina atu o Moc-L-Tert-Leucine (CAS 162537-11-3) faʻatasi ai ma le maualuga.Moc-L-Tert-Leucine o se ituaiga o amino acid deriviative.O se mea sili ona aoga mo le faʻaogaina lelei o le HIV protease inhibitor Atazanavir (CAS 198904-31-3) faʻapea foʻi ma Atazanavir sulfate (CAS 229975-97-7).
Atazanavir ose vaila'au antiretroviral lea ua fa'amaonia e le FDA mo le fa'aogaina fa'atasi ma isi anti-RTagents mo togafitiga o fa'ama'i pipisi o le HIV.O le vailaʻau e faʻaaogaina i taimi uma faʻatasi ma RT inhibitors.O le Atazanavir o se fa'alavelave ole HIV-1 protease (EC50=2.6 nM).I totonu o sela tu'ufua, o lo'o i ai fa'aopoopoga i a'afiaga antiviral moderately synergistic pe a tu'ufa'atasia ma isi vaila'au antiretroviral.O se taunuuga, e masani ona faʻaaogaina i vivo i faʻatasiga togafitiga mo faʻamaʻi HIV-1.